Department of Biomedical Sciences

Read more
431 - 440 out of 9,776Page size: 10
Sort by: Title
  1. Published

    Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss

    Iepsen, E. W., Lundgren, J., Dirksen, C., Jensen, J., Pedersen, Oluf Borbye, Hansen, Torben, Madsbad, Sten, Holst, Jens Juul & Torekov, Signe Sørensen, 2015, In: International journal of obesity (2005). 39, 5, p. 834-41 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. E-pub ahead of print

    Treatment refractory chronic spontaneous urticaria may benefit from treatment with dupilumab: A case series of eight patients

    Feldborg, S. E. B., Thomsen, Simon Francis & Vestergaard, C., 2024, (E-pub ahead of print) In: Journal of the European Academy of Dermatology and Venereology.

    Research output: Contribution to journal › Letter › Research › peer-review

  3. Published

    Treatment of type 2 diabetes with glucagonlike peptide 1

    Holst, Jens Juul, 1998, In: Current Opinion in Endocrin. and Diabetes. 5, p. 108-115

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists

    Hansen, K. B., Knop, Filip Krag, Holst, Jens Juul & Vilsbøll, Tina, 2009, In: International Journal of Clinical Practice. 63, 8, p. 1154-60 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.

    Holst, Jens Juul, 2004, In: Expert Opinion on Emerging Drugs. 9, 1, p. 155-66 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Treatment of type 2 diabetes by targeting interleukin-1: a meta-analysis of 2921 patients

    Kataria, Y., Ellervik, Christina & Mandrup-Poulsen, Thomas, 2019, In: Seminars in Immunopathology. 41, 4, p. 413-425

    Research output: Contribution to journal › Review › Research › peer-review

  7. Published

    Treatment of type 1 diabetic patients with glucagon-like peptide-1 (GLP-1) and GLP-1R agonists

    Kielgast, U., Holst, Jens Juul & Madsbad, Sten, Nov 2009, In: Current Diabetes Reviews. 5, 4, p. 266-75 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Treatment of subclinical hyperthyroidism: effect on left ventricular mass and function of the heart using magnetic resonance imaging technique

    Mark, P. D., Andreassen, Mikkel, Petersen, C. L., Kjær, Andreas & Faber, Jens, 2015, In: Endocrine Connections. 4, 1, p. 37-42 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Treatment of short bowel patients with glucagon-like peptide-2 (GLP-2), a newly discovered intestinotrophic, anti-secretory, and transit modulating peptide

    Jeppesen, P. B., Hartmann, B., Thulesen, J., Graff, J., Lohmann, J., Hansen, B. S., Tofteng, F., Poulsen, S. S., Madsen, J. L., Holst, Jens Juul & Mortensen, P. B., 2001, In: Today in Medicine. Gastroenterology. 120, p. 806-815

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol

    Hansen, Ditte, Brandi, Lisbet & Rasmussen, K., 2009, In: BMC Nephrology. 10, p. 28

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...40 41 42 43 44 45 46 47 ...978 Next